Organisational barriers to thrombolysis treatment of acute ischaemic stroke

Lars Ehlers; Lotte Groth Jensen; Merete Bech; Grethe Andersen; Mette Kjølby

Intravenous thrombolysis with fibrinolytic drugs such as alteplase is not implemented widely in any country although the treatment is both effective and cost-effective in selected patients within a 3-h window after acute ischaemic stroke. The purpose of the present study was to describe the organisational barriers to delivery of thrombolysis for acute ischaemic stroke with special regard to the Danish healthcare system. Astract: http://www.ncbi.nlm.nih.gov/pubmed/17910781

Udgivelsesform Videnskabelige artikler
År 2007
Udgiver Curr Med Res Opin. 2007 Nov;23(11):2833-9.

Forfattere

Mette Kjølby